Trial Profile
A Phase III double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of idebenone in the treatment of Friedreich's Ataxia patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Idebenone (Primary)
- Indications Friedreich's ataxia
- Focus Registrational; Therapeutic Use
- Acronyms MICONOS
- Sponsors Santhera Pharmaceuticals
- 17 May 2011 New trial record